Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS Device
Stallion Uranium Announces Flow-Through and Non-Flow Through Private Placements for Gross Proceeds of up to $12M
NextSource Materials Executes Binding Offtake Agreement with Mitsubishi Chemical Corporation to Supply SuperFlake Graphite Anode Material for the North American EV Market
SAGA Metals Confirms a 3 km Continuous Magnetic Anomaly in the Trapper Zone at the 100% Owned Radar Titanium Property in Labrador, Canada & Provides Corporate Update
